What happened with DH today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Definitive Healthcare Corp. brings together information about healthcare providers, their affiliations, referrals and treatment activity so customers can decide which markets to pursue and which healthcare audiences to reach. Drug and medical-device companies, hospitals and health systems, and other businesses serving healthcare pay to use its online data and analytics platform.
The company collects information from outside sources and its own research, then cleans, links and analyzes it. Customers buy tiered subscriptions priced by user, with additional charges for more users and analytics modules. Subscription fees account for substantially all revenue, so the business depends on customers renewing their access and expanding their use.
Those renewals depend on customers trusting the data’s coverage and accuracy. Definitive Healthcare also needs continued access to external sources, including medical claims data and government records. Privacy laws restrict how it can collect, use and share information, and the de-identified health data it uses must meet applicable legal standards.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Definitive Healthcare’s subscription results also depend on competition from private healthcare-data specialists such as Komodo Health and H1 Healthcare, neither of which appears in this list.
IQVIA competes with Definitive Healthcare for life sciences customers buying healthcare information and analytics to understand markets and guide sales and marketing. Watch demand for IQVIA’s market, prescribing and promotional data for a read on spending on commercial healthcare intelligence.
Veeva Systems competes with Definitive Healthcare for life sciences spending on data and software that support commercialization and healthcare-market targeting. Its Commercial Solutions revenue, which includes Veeva Commercial Cloud and Veeva Data Cloud, is the line to watch rather than its R&D and quality software.
ZoomInfo Technologies Inc competes with Definitive Healthcare for subscriptions paid by businesses whose sales and marketing teams need to find and target prospective customers, though Definitive Healthcare focuses on healthcare. Demand for ZoomInfo Sales and ZoomInfo Marketing offers a broader view of spending on customer acquisition, not a healthcare-only signal.
Clarivate’s Life Sciences & Healthcare business competes with Definitive Healthcare in selling healthcare intelligence, including claims data, to paying customers. Watch that business rather than Clarivate’s academia or intellectual-property operations for the closer read on healthcare-intelligence demand.
Tempus AI and Definitive Healthcare both depend on life sciences customers paying for healthcare data and analytics, with Definitive Healthcare supporting research, development and commercialization. Watch Tempus AI’s licensing of de-identified data and analytics through Insights and Lens, rather than its diagnostic testing, for the closer signal of those customers’ data spending.
IQVIA Holdings Inc. earningsIQV
IQVIA's report will show demand from life sciences companies for market, prescribing and promotional data, offering a read on the appetite for healthcare-intelligence subscriptions that Definitive Healthcare also serves.
Watch IQVIA's market, prescribing and promotional data business for life sciences customers. Steady or stronger demand would suggest commercial healthcare-intelligence budgets are holding up, supporting the setting for Definitive Healthcare's subscription sales and renewals; weaker demand would point to tighter customer spending and more pressure on those sales and renewals.
Fed Interest Rate Decision
Definitive Healthcare’s Fed interest-rate decision matters because it can change the cost of interest on the company’s variable-rate debt and reduce or preserve money left for its healthcare data subscriptions business.
Expected4.0%Last release4.0%
If it comes in above expectations
If the Fed sets rates higher than expected, interest costs on Definitive Healthcare’s variable-rate debt may rise, leaving less money after debt service to support its subscription platform and operations.
If it comes in below expectations
If the Fed sets rates lower than expected, interest costs on Definitive Healthcare’s variable-rate debt may fall, leaving more money after debt service for its subscription platform and operations.
Definitive Healthcare Corp. earningsThis company
Definitive Healthcare earns mainly from healthcare-data subscriptions, and this report will show whether shrinking revenue from existing customers is easing and new customers can make up the gap.
Read subscription revenue alongside renewal and expansion trends: steadier revenue with stable renewals and expansion would show that the customer base is holding up; weaker revenue or deteriorating renewals and expansion would show that existing-customer losses remain and new sales are not yet filling the gap.
